European monoclonal antibodies market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for monoclonal antibodies has been reported in the region, owing to the rising demand for novel monoclonal antibody therapies with higher safety and efficacy in the region. For instance, in June 2020, the European Commission […]
Category Archives: Pharmaceuticals
China monoclonal antibodies market is estimated to grow at a CAGR of nearly 9.2% during the forecast period. An increasing monoclonal antibody COVID-19 trials are offering scope for market growth. For instance, in June 2020, Chinese scientists introduced a phase I trial for the first neutralizing COVID-19 antibody treatment globally. This therapy has shown a […]
Asia-Pacific monoclonal antibodies market is estimated to grow at a CAGR of 8.9% during the forecast period. Rising cancer incidences is the major factor in accelerating market growth. As per the World Health Organization (WHO), there were 4.3 million new cancer incidences reported in the country. Of these, lung (18.1%), colorectum (12.2%), stomach (10.6%), liver […]
The North American peptide therapeutics market will see a considerable growth of 5.1% during the forecast period. The region has a significant presence of peptide therapeutics manufacturers, with extensive R&D in the peptide therapeutics market. The Peptide Therapeutics Foundation, a not-for-profit 501C (3) was also established in 2008 in the region with the intention to […]
The UK peptide therapeutics market will see a considerable growth of 3.7% during the forecast period. Well established healthcare infrastructure is also one of the key reasons which are expected to promote the acceptance of peptide therapeutics in the UK for the treatment of various health conditions, such as CVD, cancer, and others. The market […]
The German peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. As per the report published by the German Diabetes Center (DDZ), in 2019 more than 7.2% of the population in Germany suffered from diabetes, most of them suffering from Type 2 diabetes. The report estimates that the number of […]
The European peptide therapeutics market will see a considerable growth of 4.3% during the forecast period. The region has a significant presence of peptide therapeutics industry players, with extensive R&D in the market. With the increase in the number of cases of cancer in the region, the demand for proper treatment and availability of drugs […]
China’s peptide therapeutics market will see a considerable growth of 6.8% during the forecast period. Since the last decade, China has emerged as a globally preferred destination for the outsourcing of drug research. The robust growth of China’s Contract Research (CRO) industry is encouraging the transition of outsourcing services at a large scale, thereby contributing […]
The European neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). The key factors that primarily flourish the growth of the market include the rising geriatric population along with the rising prevalence of neurological disorders. As per the European Academy of Neurology 2019, around 60% of the population suffers from […]
The Asia-Pacific Peptide Therapeutics Market will see a considerable growth of 6.7% during the forecast period. Asia-Pacific is one of the promising regions in the field of peptides. The frequent collaboration of various global and domestic companies through workshops and seminars is also expected to present a new growth opportunity for the Asia-Pacific Peptide Therapeutics […]